Accelerate Diagnostics, Inc. (AXDX) Financials
AXDX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 39.3 million | 74.4 million |
2023-06-30 | 49.9 million | 88.5 million |
2023-03-31 | 51.0 million | 89.7 million |
2022-12-31 | 65.0 million | 87.3 million |
AXDX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -9.0 million | 1.8 million |
2023-06-30 | -11.0 million | 1.7 million |
2023-03-31 | -13.4 million | 555000 |
2022-12-31 | -9.7 million | 2.4 million |
AXDX Net Income
No data available :(
AXDX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 21.2 million | - | 2.5 million |
2023-06-30 | 30.7 million | 32.3 million | 3.6 million |
2023-03-31 | 31.9 million | - | 4.0 million |
2022-12-31 | 45.6 million | 49.6 million | 4.3 million |
AXDX Shares Outstanding
AXDX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 758000 | 7.0 million | 7.8 million | - |
2023-06-30 | 155000 | 5.8 million | 7.6 million | - |
2023-03-31 | 12000 | 7.0 million | 10.1 million | - |
2022-12-31 | 108000 | 6.0 million | 8.3 million | - |
AXDX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 3.3 million | 3.2 million |
2023-06-30 | 2.9 million | 2.1 million |
2023-03-31 | 2.8 million | 1.8 million |
2022-12-31 | 3.0 million | 2.3 million |
AXDX
Price: $0.92
52 week price:
Earnings Per Share: -5.52 USD
P/E Ratio: -0.20
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 335200
Ebitda: -16.0 millionMarket Capitalization: 19.2 million